CCI
Columbus Circle Investors Portfolio holdings
AUM
$2.28B
1-Year Return
135.58%
This Quarter Return
+0.54%
1 Year Return
+135.58%
3 Year Return
+366.07%
5 Year Return
+793.68%
10 Year Return
–
AUM
$11.2B
AUM Growth
-$1.13B
(-9.2%)
Cap. Flow
-$761M
Cap. Flow
% of AUM
-6.79%
Top 10 Holdings %
Top 10 Hldgs %
25.36%
Holding
324
New
63
Increased
85
Reduced
105
Closed
69
Top Buys
| 1 |
Microsoft
MSFT
|
+$176M |
| 2 |
Procter & Gamble
PG
|
+$134M |
| 3 |
Kellanova
K
|
+$90.6M |
| 4 |
Capri Holdings
CPRI
|
+$86.8M |
| 5 |
McDonald's
MCD
|
+$79M |
Top Sells
| 1 |
McKesson
MCK
|
+$159M |
| 2 |
Nike
NKE
|
+$157M |
| 3 |
Booking.com
BKNG
|
+$151M |
| 4 |
Amazon
AMZN
|
+$97.9M |
| 5 |
DATA
Tableau Software, Inc.
DATA
|
+$86.5M |
Sector Composition
| 1 | Technology | 20.85% |
| 2 | Healthcare | 19.68% |
| 3 | Consumer Discretionary | 18.32% |
| 4 | Financials | 9.97% |
| 5 | Industrials | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Acadia Healthcare
ACHC
$2.15B
| $1.62M | 0.01% |
29,441
+5,181
| +21% | +$285K |
|
227
Amicus Therapeutics
FOLD
$2.43B
| $1.38M | 0.01% |
163,333
-64,556
| -28% | -$545K |
|
|
TLGT
228
DELISTED
Teligent, Inc
TLGT
| $1.36M | 0.01% |
27,769
-703
| -2% | -$34.5K |
|
229
Rocket Pharmaceuticals
RCKT
$346M
| $1.36M | 0.01% |
45,818
+15,601
| +52% | +$462K |
|
230
MACOM Technology Solutions
MTSI
$9.67B
| $1.28M | 0.01% |
29,198
+16,348
| +127% | +$716K |
|
231
Belden
BDC
$5.07B
| $1.15M | 0.01% |
+18,786
| New | +$1.15M |
|
232
Trip.com Group
TCOM
$47.3B
| $1.12M | 0.01% |
+25,330
| New | +$1.12M |
|
233
JD.com
JD
$48B
| $1.11M | 0.01% |
+41,925
| New | +$1.11M |
|
|
RVNC
234
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.11M | 0.01% |
63,398
+2,103
| +3% | +$36.7K |
|
235
NETSCOUT
NTCT
$1.8B
| $1.07M | 0.01% |
+46,520
| New | +$1.07M |
|
|
GIMO
236
DELISTED
Gigamon Inc.
GIMO
| $933K | 0.01% |
+30,090
| New | +$933K |
|
|
INXN
237
DELISTED
Interxion Holding N.V.
INXN
| $890K | 0.01% |
25,749
+2,099
| +9% | +$72.6K |
|
238
Vanda Pharmaceuticals
VNDA
$266M
| $874K | 0.01% |
+104,574
| New | +$874K |
|
239
Sangamo Therapeutics
SGMO
$157M
| $859K | 0.01% |
141,996
-435,197
| -75% | -$2.63M |
|
240
Synaptics
SYNA
$2.7B
| $858K | 0.01% |
10,761
-4,364
| -29% | -$348K |
|
|
OCLR
241
DELISTED
Oclaro Inc.
OCLR
| $822K | 0.01% |
+152,165
| New | +$822K |
|
|
PETX
242
DELISTED
Aratana Therapeutics, Inc.
PETX
| $795K | 0.01% |
144,106
+19,667
| +16% | +$108K |
|
|
EMWP
243
DELISTED
Eros Media World PLC
EMWP
| $789K | 0.01% |
3,427
+2,636
| +333% | +$607K |
|
|
ACHN
244
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $583K | 0.01% |
75,454
-170,680
| -69% | -$1.32M |
|
245
DHT Holdings
DHT
$1.96B
| $576K | 0.01% |
100,000
-150,000
| -60% | -$864K |
|
246
Trimble
TRMB
$19.1B
| $441K | ﹤0.01% |
17,770
-36,186
| -67% | -$898K |
|
247
Catalyst Pharmaceutical
CPRX
$2.45B
| $419K | ﹤0.01% |
358,078
-60,306
| -14% | -$70.6K |
|
|
AVDL
248
Avadel Pharmaceuticals
AVDL
$1.51B
| $335K | ﹤0.01% |
30,355
-43,060
| -59% | -$475K |
|
|
AMED
249
DELISTED
Amedisys
AMED
| $317K | ﹤0.01% |
6,560
-16,685
| -72% | -$806K |
|
250
Akamai
AKAM
$11.2B
| $297K | ﹤0.01% |
+5,340
| New | +$297K |
|